Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen

Developing broadly applicable neoantigen-directed adoptive cell therapies (ACTs) is challenging because each cancer patient has an unique neoantigen repertoire. Here, the authors present the crystal structures of tumor-specific T cell receptors (TCRs) that recognize a shared neoepitope arising from...

Full description

Bibliographic Details
Main Authors: Daichao Wu, D. Travis Gallagher, Ragul Gowthaman, Brian G. Pierce, Roy A. Mariuzza
Format: Article
Language:English
Published: Nature Portfolio 2020-06-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-16755-y
_version_ 1819037004927598592
author Daichao Wu
D. Travis Gallagher
Ragul Gowthaman
Brian G. Pierce
Roy A. Mariuzza
author_facet Daichao Wu
D. Travis Gallagher
Ragul Gowthaman
Brian G. Pierce
Roy A. Mariuzza
author_sort Daichao Wu
collection DOAJ
description Developing broadly applicable neoantigen-directed adoptive cell therapies (ACTs) is challenging because each cancer patient has an unique neoantigen repertoire. Here, the authors present the crystal structures of tumor-specific T cell receptors (TCRs) that recognize a shared neoepitope arising from the R175H driver mutation in the p53 oncogene (p53R175H) alone and bound to p53R175H–HLA-A2, which are of interest for the structure-guided design of TCRs to improve T cell potency for ACT.
first_indexed 2024-12-21T08:14:32Z
format Article
id doaj.art-539421cdbf2649ba84e049f00249ee1a
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-21T08:14:32Z
publishDate 2020-06-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-539421cdbf2649ba84e049f00249ee1a2022-12-21T19:10:36ZengNature PortfolioNature Communications2041-17232020-06-0111111210.1038/s41467-020-16755-yStructural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigenDaichao Wu0D. Travis Gallagher1Ragul Gowthaman2Brian G. Pierce3Roy A. Mariuzza4W.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology ResearchW.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology ResearchW.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology ResearchW.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology ResearchW.M. Keck Laboratory for Structural Biology, University of Maryland Institute for Bioscience and Biotechnology ResearchDeveloping broadly applicable neoantigen-directed adoptive cell therapies (ACTs) is challenging because each cancer patient has an unique neoantigen repertoire. Here, the authors present the crystal structures of tumor-specific T cell receptors (TCRs) that recognize a shared neoepitope arising from the R175H driver mutation in the p53 oncogene (p53R175H) alone and bound to p53R175H–HLA-A2, which are of interest for the structure-guided design of TCRs to improve T cell potency for ACT.https://doi.org/10.1038/s41467-020-16755-y
spellingShingle Daichao Wu
D. Travis Gallagher
Ragul Gowthaman
Brian G. Pierce
Roy A. Mariuzza
Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
Nature Communications
title Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
title_full Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
title_fullStr Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
title_full_unstemmed Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
title_short Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
title_sort structural basis for oligoclonal t cell recognition of a shared p53 cancer neoantigen
url https://doi.org/10.1038/s41467-020-16755-y
work_keys_str_mv AT daichaowu structuralbasisforoligoclonaltcellrecognitionofasharedp53cancerneoantigen
AT dtravisgallagher structuralbasisforoligoclonaltcellrecognitionofasharedp53cancerneoantigen
AT ragulgowthaman structuralbasisforoligoclonaltcellrecognitionofasharedp53cancerneoantigen
AT briangpierce structuralbasisforoligoclonaltcellrecognitionofasharedp53cancerneoantigen
AT royamariuzza structuralbasisforoligoclonaltcellrecognitionofasharedp53cancerneoantigen